adyn
About adyn
Founded by Dr. Elizabeth Ruzzo, adyn is helping people find birth control without side effects based on a person's genetic risk and hormone profile. Despite the 47M birth control users in the US, virtually no studies examine the biological factors that explain why individuals respond differently to a given contraceptive method.Launched in May 2022, The Birth Control Test is the first test designed to prevent birth control side effects. While we are improving the birth control experience, we are also committed to closing the gender health gap. By partnering with individuals, adyn leverages personal preference, medical history, and biological data to proactively help every (unique) body select the most desirable birth control option – with the least dangerous side effects.Our vision is to be earth's most inclusive and patient-centric personalized medicine company. When a person uses The Birth Control Test, they can opt in as an anonymous research participant to help close these research gaps. This means you can simultaneously find the right birth control for your body, while helping others do the same.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 2.5M None
- Last Funding: 2.5M None (None)
- Funding Status: None
Technology Stack
adyn actively uses None products in their tech stack.
Market Presence
Industries: Research, Research, Biotechnology research
Headquarters: Seattle, Washington